Related Experiment Video
Updated: Jun 26, 2025
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
658
Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study.
Yonghua Gao1, Hollian Richardson2, Alison J Dicker2
1Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Summary
Bronchiectasis exacerbations are complex events driven by bacteria, viruses, and inflammation. Understanding these triggers is key to managing this lung condition.
Area of Science:
- Pulmonary Medicine
- Microbiology
- Immunology
Background:
- Bronchiectasis exacerbations have poorly understood biological mechanisms.
- Acute exacerbations significantly impact patient health and disease progression.
Purpose of the Study:
- To investigate the inflammatory and microbial characteristics of bronchiectasis exacerbations.
- To identify distinct subtypes of exacerbations based on molecular profiles.
Main Methods:
- Collected sputum samples from 120 bronchiectasis patients during stable periods and exacerbations.
- Utilized PCR for bacterial and viral detection, mass spectrometry for proteomics, and 16S rRNA sequencing for microbiome analysis.
- Assessed sputum cytokines and neutrophil elastase activity.
Main Results:
- Exacerbations displayed significant molecular heterogeneity, with bacteria detected in 86% and viruses in 46% of samples.
- Increased levels of neutrophil elastase, proteinase-3, IL-1β, and CXCL8 were associated with bacterial and viral exacerbations.
- Integrated analysis revealed four distinct exacerbation subtypes based on inflammatory and microbiome profiles.
Conclusions:
- Bronchiectasis exacerbations are heterogeneous, involving bacteria, viruses, and inflammatory dysregulation.
- Distinct molecular profiles characterize different exacerbation subtypes, aiding in targeted management.
- Further research into these subtypes can improve treatment strategies for bronchiectasis.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
197
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K